The Goldman Sachs Group assumed coverage on shares of Altimmune (NASDAQ:ALT – Free Report) in a report released on Wednesday, MarketBeat reports. The brokerage issued a neutral rating and a $13.00 price target on the stock. ALT has been the topic of a number of other research reports. HC Wainwright restated a buy rating and […]
Altimmune (NASDAQ:ALT) Coverage Initiated at The Goldman Sachs Group themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Altimmune (NASDAQ:ALT) Trading Down 4 1% themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Altimmune, Inc. (NASDAQ:ALT – Free Report) – Research analysts at HC Wainwright issued their FY2028 EPS estimates for shares of Altimmune in a report released on Friday, January 19th. HC Wainwright analyst P. Trucchio forecasts that the company will post earnings per share of $0.26 for the year. HC Wainwright currently has a “Buy” rating […]
Altimmune, Inc. (NASDAQ:ALT – Free Report) – Stock analysts at HC Wainwright issued their FY2028 EPS estimates for shares of Altimmune in a note issued to investors on Friday, January 19th. HC Wainwright analyst P. Trucchio expects that the company will post earnings of $0.26 per share for the year. HC Wainwright currently has a […]